CereVasc

Paper Craft Purple Human Brain on Purple Background Front View.

CereVasc Rakes In $85M to Challenge Traditional Brain Shunt Surgery

CereVasc raised $85 million in Series C funding to advance its minimally invasive eShunt system, which aims to treat hydrocephalus without traditional brain shunt surgery. The company is preparing for a pivotal trial completion and FDA submission in 2027.

By Katie Adams

Funding roundup: Billing automation startup Alpha Health raises $20M

Alpha Health, a startup looking to automate revenue cycle management, raised $20 million in funding from Andreesen Horowitz. Read more about startups that announced funding rounds this week.

By Elise Reuter - Medcity News

The Power of Real World Data to Study Women’s Health at Scale

Veradigm examines key clinical trends, comorbidity profiles, and treatment trends across adolescence, reproductive years, and peri-/post-menopause. Download it today!

By Veradigm and MedCity News